Abel Sandmann

Abel Sandmann, clinical researcher at Amsterdam UMC studying cerebrovascular malformations and epilepsy. He discusses when a first unprovoked seizure with a cerebral cavernous malformation meets criteria for epilepsy. He reviews low 10-year risk for first seizures in incidental CCMs. He highlights the high recurrence risk after a first seizure and how medical therapy often achieves long-term seizure freedom.

Abel Sandmann, a clinical neurologist researching cerebral cavernous malformations (CCMs) and epilepsy. He explains CCM features and how blood products provoke seizures. Long-term Scottish cohort data on seizure risk and recurrence are discussed. Treatment themes include anti-seizure medication outcomes, timing of interventions, and when neurosurgical referral is appropriate.